R Padwal1, F A McAlister1, J J V McMurray2, M R Cowie3, M Rich4, S Pocock5, K Swedberg6, A Maggioni7, G Gamble8, C Ariti5, N Earle8, G Whalley9, K K Poppe8, R N Doughty8, A Bayes-Genis10. 1. Department of Medicine, University of Alberta, Edmonton, Canada. 2. BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. 3. Faculty of Medicine, National Heart and Lung Institute, Imperial College London (Royal Brompton Hospital), London, UK. 4. Washington University School of Medicine, St Louis, MO, USA. 5. Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK. 6. Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 7. ANMCO Research Center, Florence, Italy. 8. Department of Medicine and National Institute for Health Innovation, University of Auckland, Auckland, New Zealand. 9. Faculty of Social and Health Sciences, UNITEC Institute of Technology, Auckland, New Zealand. 10. Department of Medicine, Hospital Universitari Germans Trias i Pujol UAB, Barcelona, Spain.
Abstract
BACKGROUND: In heart failure (HF), obesity, defined as body mass index (BMI) ≥30 kg m(-2), is paradoxically associated with higher survival rates compared with normal-weight patients (the 'obesity paradox'). We sought to determine if the obesity paradox differed by HF subtype (reduced ejection fraction (HF-REF) versus preserved ejection fraction (HF-PEF)). PATIENTS AND METHODS: A sub-analysis of the MAGGIC meta-analysis of patient-level data from 14 HF studies was performed. Subjects were divided into five BMI groups: <22.5, 22.5-24.9 (referent), 25-29.9, 30-34.9 and ≥35 kg m(-2). Cox proportional hazards models adjusted for age, sex, aetiology (ischaemic or non-ischaemic), hypertension, diabetes and baseline blood pressure, stratified by study, were used to examine the independent association between BMI and 3-year total mortality. Analyses were conducted for the overall group and within HF-REF and HF-PEF groups. RESULTS: BMI data were available for 23 967 subjects (mean age, 66.8 years; 32% women; 46% NYHA Class II; 50% Class III) and 5609 (23%) died by 3 years. Obese patients were younger, more likely to receive cardiovascular (CV) drug treatment, and had higher comorbidity burdens. Compared with BMI levels between 22.5 and 24.9 kg m(-2), the adjusted relative hazards for 3-year mortality in subjects with HF-REF were: hazard ratios (HR)=1.31 (95% confidence interval=1.15-1.50) for BMI <22.5, 0.85 (0.76-0.96) for BMI 25.0-29.9, 0.64 (0.55-0.74) for BMI 30.0-34.9 and 0.95 (0.78-1.15) for BMI ≥35. Corresponding adjusted HRs for those with HF-PEF were: 1.12 (95% confidence interval=0.80-1.57) for BMI <22.5, 0.74 (0.56-0.97) for BMI 25.0-29.9, 0.64 (0.46-0.88) for BMI 30.0-34.9 and 0.71 (0.49-1.05) for BMI ≥35. CONCLUSIONS: In patients with chronic HF, the obesity paradox was present in both those with reduced and preserved ventricular systolic function. Mortality in both HF subtypes was U-shaped, with a nadir at 30.0-34.9 kg m(-2).
BACKGROUND: In heart failure (HF), obesity, defined as body mass index (BMI) ≥30 kg m(-2), is paradoxically associated with higher survival rates compared with normal-weight patients (the 'obesity paradox'). We sought to determine if the obesity paradox differed by HF subtype (reduced ejection fraction (HF-REF) versus preserved ejection fraction (HF-PEF)). PATIENTS AND METHODS: A sub-analysis of the MAGGIC meta-analysis of patient-level data from 14 HF studies was performed. Subjects were divided into five BMI groups: <22.5, 22.5-24.9 (referent), 25-29.9, 30-34.9 and ≥35 kg m(-2). Cox proportional hazards models adjusted for age, sex, aetiology (ischaemic or non-ischaemic), hypertension, diabetes and baseline blood pressure, stratified by study, were used to examine the independent association between BMI and 3-year total mortality. Analyses were conducted for the overall group and within HF-REF and HF-PEF groups. RESULTS: BMI data were available for 23 967 subjects (mean age, 66.8 years; 32% women; 46% NYHA Class II; 50% Class III) and 5609 (23%) died by 3 years. Obesepatients were younger, more likely to receive cardiovascular (CV) drug treatment, and had higher comorbidity burdens. Compared with BMI levels between 22.5 and 24.9 kg m(-2), the adjusted relative hazards for 3-year mortality in subjects with HF-REF were: hazard ratios (HR)=1.31 (95% confidence interval=1.15-1.50) for BMI <22.5, 0.85 (0.76-0.96) for BMI 25.0-29.9, 0.64 (0.55-0.74) for BMI 30.0-34.9 and 0.95 (0.78-1.15) for BMI ≥35. Corresponding adjusted HRs for those with HF-PEF were: 1.12 (95% confidence interval=0.80-1.57) for BMI <22.5, 0.74 (0.56-0.97) for BMI 25.0-29.9, 0.64 (0.46-0.88) for BMI 30.0-34.9 and 0.71 (0.49-1.05) for BMI ≥35. CONCLUSIONS: In patients with chronic HF, the obesity paradox was present in both those with reduced and preserved ventricular systolic function. Mortality in both HF subtypes was U-shaped, with a nadir at 30.0-34.9 kg m(-2).
Authors: Finn Gustafsson; Charlotte B Kragelund; Christian Torp-Pedersen; Marie Seibaek; Hans Burchardt; Dilek Akkan; Jens Jakob Thune; Lars Køber Journal: Eur Heart J Date: 2004-11-30 Impact factor: 29.983
Authors: Stuart J Pocock; Cono A Ariti; John J V McMurray; Aldo Maggioni; Lars Køber; Iain B Squire; Karl Swedberg; Joanna Dobson; Katrina K Poppe; Gillian A Whalley; Rob N Doughty Journal: Eur Heart J Date: 2012-10-24 Impact factor: 29.983
Authors: Paul A McAuley; Enrique G Artero; Xuemei Sui; Duck-chul Lee; Timothy S Church; Carl J Lavie; Jonathan N Myers; Vanesa España-Romero; Steven N Blair Journal: Mayo Clin Proc Date: 2012-04-12 Impact factor: 7.616
Authors: Carl J Lavie; Lawrence P Cahalin; Paul Chase; Jonathan Myers; Daniel Bensimhon; Mary Ann Peberdy; Euan Ashley; Erin West; Daniel E Forman; Marco Guazzi; Ross Arena Journal: Mayo Clin Proc Date: 2013-02-27 Impact factor: 7.616
Authors: Carl J Lavie; Richard V Milani; Surya M Artham; Dharmendrakumar A Patel; Hector O Ventura Journal: Am J Med Date: 2009-08-13 Impact factor: 4.965
Authors: Carl J Lavie; Martin A Alpert; Ross Arena; Mandeep R Mehra; Richard V Milani; Hector O Ventura Journal: JACC Heart Fail Date: 2013-04-01 Impact factor: 12.035
Authors: Tiffany M Powell-Wiley; Julius Ngwa; Selomie Kebede; Di Lu; Phillip J Schulte; Deepak L Bhatt; Clyde Yancy; Gregg C Fonarow; Michelle A Albert Journal: JACC Heart Fail Date: 2018-02-07 Impact factor: 12.035
Authors: Andrew T Strong; Gautam Sharma; Chao Tu; Ali Aminian; James B Young; John Rodriguez; Matthew Kroh Journal: Obes Surg Date: 2018-08 Impact factor: 4.129